Your browser doesn't support javascript.
loading
Biological and clinical research progress of MITF in melanoma / 肿瘤
Tumor ; (12): 1130-1134, 2013.
Article de Zh | WPRIM | ID: wpr-848901
Bibliothèque responsable: WPRO
ABSTRACT
Melanoma arises from the melanocyte cell lineage, it is one of the most notoriously aggressive and treatment-resistant human cancers. Microphthalmia-associated transcription factor (MITF) acts as a master regulator of melanocyte's development, function and survival by modulating various differentiation and cell-cycle progression genes. It also plays an oncogenic role in melanoma. MITF targeting genes important in melanoma progression include promoting survival and blocking apoptosis, stimulating proliferation, and inhibiting cell cycle. This review summarized the molecular function of MITF and its related pathways, and hope it will shed light on strategies for improving therapeutic approaches for melanoma. Copyright © 2013 by TUMOR.
Mots clés
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Tumor Année: 2013 Type: Article
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Tumor Année: 2013 Type: Article